Altered bone development and turnover in transgenic mice over-expressing Lipocalin-2 in bone

Journal of Cellular Physiology

Volumn 228, Issue 11, 2013, Pages 2210-2221

  Costa, Delfina ^a   Lazzarini, Edoardo ^a   Canciani, Barbara ^a   Giuliani, Alessandra ^b   Spanò, Raffaele ^a   Marozzi, Katia ^b   Manescu, Adrian ^b   Cancedda, Ranieri ^a   Tavella, Sara ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; INTERLEUKIN 6; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MASS; BONE TURNOVER; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CORTICAL BONE; ENCHONDRAL OSSIFICATION; GROWTH PLATE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRABECULAR BONE;

ACID PHOSPHATASE; ACUTE-PHASE PROTEINS; ANIMALS; ANIMALS, NEWBORN; BODY SIZE; BONE DEVELOPMENT; BONE REMODELING; BONE RESORPTION; CELL DIFFERENTIATION; FEMUR; GROWTH PLATE; INTERLEUKIN-6; ISOENZYMES; LIPOCALINS; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; RECEPTORS, CELL SURFACE; REPRODUCIBILITY OF RESULTS; TRANSGENES;

EID: 84881228692     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24391     Document Type: Article

References (45)

1. Akerstrom B, Flower DR, Salier JP. 2000. Lipocalins: Unity in diversity. Biochim Biophys Acta 1482:1-8.
2. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. 2000. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 275:4858-4864.
3. Blottner D, Serradj N, Salanova M, Touma C, Palme R, Silva M, Aerts JM, Berckmans D, Vico L, Liu Y, Giuliani A, Rustichelli F, Cancedda R, Jamon M. 2009. Morphological, physiological and behavioural evaluation of a 'Mice in Space' housing system. J Comp Physiol B 179:519-533.
4. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. 1998. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268.
5. Cancedda R, Castagnola P, Cancedda FD, Dozin B, Quarto R. 2000. Developmental control of chondrogenesis and osteogenesis. Int J Dev Biol 44:707-714.
6. Capulli M, Rufo A, Teti A, Rucci N. 2009. Global transcriptome analysis in mouse calvarial osteoblasts highlights sets of genes regulated by modeled microgravity and identifies a "mechanoresponsive osteoblast gene signature". J Cell Biochem 107:240-252.
7. Chitteti BR, Cheng YH, Streicher DA, Rodriguez-Rodriguez S, Carlesso N, Srour EF, Kacena MA. 2010. Osteoblast lineage cells expressing high levels of Runx2 enhance hematopoietic progenitor cell proliferation and function. J Cell Biochem 111:284-294.
8. Costa D, Biticchi R, Negrini S, Tasso R, Cancedda R, Descalzi F, Pennesi G, Tavella S. 2010. Lipocalin-2 controls the expression of SDF-1 and the number of responsive cells in bone. Cytokine 51:47-52.
9. De Benedetti F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Longo M, Vivarelli M, Muratori F, Berni S, Ballanti P, Ferrari S, Teti A. 2006. Impaired skeletal development in interleukin-6-transgenic mice: A model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum 54:3551-3563.
10. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. 2004. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917-921.
11. Flower DR, North AC, Sansom CE. 2000. The lipocalin protein family: Structural and sequence overview. Biochim Biophys Acta 1482:9-24.
12. Franchimont N, Wertz S, Malaise M. 2005. Interleukin-6: An osteotropic factor influencing bone formation? Bone 37:601-606.
13. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P. 2002. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol 22:6222-6233.
14. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. 2003. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1-20.
15. Hildebrand T, Ruegsegger P. 1997. A new method for the model-independent assessment of thickness in three-dimensional images. J Microsc Oxford 185:67-75.
16. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T. 1990. Il-6 is produced by osteoblasts and induces bone-resorption. J Immunol 145:3297-3303.
17. Kamimura D, Ishihara K, Hirano T. 2003. IL-6 signal transduction and its physiological roles: The signal orchestration model. Rev Physiol Biochem Pharmacol 149:1-38.
18. Kjeldsen L, Cowland JB, Borregaard N. 2000. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 1482:272-283.
19. Kollet O, Dar A, Lapidot T. 2007. The multiple roles of osteoclasts in host defense: Bone remodeling and hematopoietic stem cell mobilization. Annu Rev Immunol 25:51-69.
20. Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA. 2003. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32:1-7.
21. Kuhn JL, Goldstein SA, Feldkamp LA, Goulet RW, Jesion G. 1990. Evaluation of a microcomputed tomography system to study trabecular bone structure. J Orthop Res 8:833-842.
22. Li Y, Backesjo CM, Haldosen LA, Lindgren U. 2008. IL-6 receptor expression and IL-6 effects change during osteoblast differentiation. Cytokine 43:165-173.
23. Liu Q, Nilsen-Hamilton M. 1995. Identification of a new acute phase protein. J Biol Chem 270:22565-22570.
24. Liu Q, Ryon J, Nilsen-Hamilton M. 1997. Uterocalin: A mouse acute phase protein expressed in the uterus around birth. Mol Reprod Dev 46:507-514.
25. Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A, Komori T. 2001. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 155:157-166.
26. Lorenzo J, Horowitz M, Choi Y. 2008. Osteoimmunology: Interactions of the bone and immune system. Endocr Rev 29:403-440.
27. Mackie EJ. 2003. Osteoblasts: Novel roles in orchestration of skeletal architecture. Int J Biochem Cell Biol 35:1301-1305.
28. Mackie EJ, Tatarczuch L, Mirams M. 2011. The skeleton: A multi-functional complex organ: The growth plate chondrocyte and endochondral ossification. J Endocrinol 211:109-121.
29. Meheus LA, Fransen LM, Raymackers JG, Blockx HA, Van Beeumen JJ, Van Bun SM, Van de Voorde A. 1993. Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. J Immunol 151:1535-1547.
30. Nilsen-Hamilton M, Liu Q, Ryon J, Bendickson L, Lepont P, Chang Q. 2003. Tissue involution and the acute phase response. Ann NY Acad Sci 995:94-108.
31. Owen HC, Roberts SJ, Ahmed SF, Farquharson C. 2008. Dexamethasone-induced expression of the glucocorticoid response gene lipocalin 2 in chondrocytes. Am J Physiol Endocrinol Metab 294:E1023-E1034.
32. Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS. 1983. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409.
33. Pflanz S, Kurth I, Grotzinger J, Heinrich PC, Muller-Newen G. 2000. Two different epitopes of the signal transducer gp130 sequentially cooperate on IL-6-induced receptor activation. J Immunol 165:7042-7049.
34. Richardson DR. 2005. 24p3 and its receptor: Dawn of a new iron age? Cell 123:1175-1177.
35. Ryon J, Bendickson L, Nilsen-Hamilton M. 2002. High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J 367:271-277.
36. Schiltz C, Prouillet C, Marty C, Merciris D, Collet C, de Vernejoul MC, Geoffroy V. 2010. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1. J Cell Physiol 222:219-229.
37. Shum L, Coleman CM, Hatakeyama Y, Tuan RS. 2003. Morphogenesis and dysmorphogenesis of the appendicular skeleton. Birth Defects Res C Embryo Today 69:102-122.
38. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
39. Sims NA, Jenkins BJ, Quinn JM, Nakamura A, Glatt M, Gillespie MT, Ernst M, Martin TJ. 2004. Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J Clin Invest 113:379-389.
40. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T. 1993. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90:11924-11928.
41. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
42. Ulivi V, Cancedda R, Cancedda FD. 2008. 15-deoxy-delta 12, 14-prostaglandin J (2) inhibits the synthesis of the acute phase protein SIP24 in cartilage: Involvement of COX-2 in resolution of inflammation. J Cell Physiol 217:433-441.
43. Yang J, Mori K, Li JY, Barasch J. 2003. Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol 285:F9-18.
44. Zankl A, Neumann L, Ignatius J, Nikkels P, Schrander-Stumpel C, Mortier G, Omran H, Wright M, Hilbert K, Bonafe L, Spranger J, Zabel B, Superti-Furga A. 2005. Dominant negative mutations in the C-propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies. Am J Med Genet Part A 133A:61-67.
45. Zerega B, Cermelli S, Michelis B, Cancedda R, Cancedda FD. 2000. Expression of NRL/NGAL (neu-related lipocalin/neutrophil gelatinase-associated lipocalin) during mammalian embryonic development and in inflammation. Eur J Cell Biol 79:165-172.